Table 3. Crude cancer incidence rates in patients and in the general population of French women (by decreasing order of SIR).

	Patients	General population
Second malignancy	Crude incidence rates 100 000 PY		SIR	95% CI	P
Leukaemia	30.4	8.7	2.07	1.52–2.75	<0.0001
Ovarian	47.6	14.9	1.6	1.27–2.04	<0.0001
Gynaecological	86.0	28.0	1.6	1.34–1.89	<0.0001
Lung	37.5	15.2	1.2	0.91–1.55	0.16
Malignant melanoma	23.9	13.8	1.07	0.76–1.48	0.67
Lymphoma	26.9	16.6	0.95	0.68–1.29	0.76
Genitourinary	26.6	15.8	0.89	0.64–1.20	0.44
Thyroid	12.9	9.6	0.87	0.53–1.35	0.54
Gastrointestinal	119.1	15.9	0.82	0.70–0.95	0.007
Head and neck	11.6	9.1	0.64	0.38–1.01	0.06
Sarcoma	22.3	NAa	—	—	—

Abbreviations: CI=confidence interval; PY=person-years; SIR=standardized incidence ratio.

^aNA, not available by age for the general population of French women.